Chronic Dry Eye Therapy
| Reference number | |
| Coordinator | Redwood Pharma AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | November 2012 - April 2013 |
| Status | Completed |
Important results from the project
Redwood Pharma AB has achieved its goals of strengthening its Intellectual Property through the development of an innovative system of delivering therapeutic medicines to the corneal surface of the eye. The Company has expanded its network of investors including venture capitalists to financially strengthen the company for it future growth.
Expected long term effects
With a brighter horizon to secure valuable intellectual property that company has initiated and continued negotiations concerning the financing of the company, moving the firm further along in securing the economic stability of the firm and to accelerate product development.
Approach and implementation
With the critical assistance of VINNOVA, Redwood Pharma has been able to move further in its discussions with potential investors. The Company has been able to meet, present and discuss our life science opportunity. Our discussions with investors and other technology companies have been key to the Redwood´s development.